Oppenheimer Has Lowered Expectations for Teladoc Health (NYSE:TDOC) Stock Price

Teladoc Health (NYSE:TDOC) had its target price lowered by Oppenheimer from $14.00 to $12.00 in a report released on Friday morning,Benzinga reports. Oppenheimer currently has an outperform rating on the health services provider’s stock.

Several other brokerages have also recently issued reports on TDOC. Piper Sandler restated an “overweight” rating and issued a $13.00 target price (up previously from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. Deutsche Bank Aktiengesellschaft upped their price target on Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Evercore ISI lifted their price target on shares of Teladoc Health from $8.00 to $9.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. TD Cowen decreased their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a report on Thursday, October 31st. Finally, Royal Bank of Canada increased their price target on shares of Teladoc Health from $9.00 to $10.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 9th. Fourteen equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $12.08.

Teladoc Health Stock Down 0.8 %

TDOC opened at $10.06 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. Teladoc Health has a one year low of $6.76 and a one year high of $21.74. The firm has a market capitalization of $1.73 billion, a P/E ratio of -1.74 and a beta of 1.01. The company has a fifty day moving average price of $10.01 and a 200-day moving average price of $9.04.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.10. The business had revenue of $640.51 million during the quarter, compared to analysts’ expectations of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Equities research analysts expect that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the company’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the transaction, the insider now directly owns 2,890 shares in the company, valued at $34,477.70. This represents a 45.25 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.95% of the stock is owned by insiders.

Institutional Investors Weigh In On Teladoc Health

Several hedge funds have recently made changes to their positions in TDOC. American Century Companies Inc. grew its stake in Teladoc Health by 31.0% during the 2nd quarter. American Century Companies Inc. now owns 136,351 shares of the health services provider’s stock worth $1,334,000 after buying an additional 32,240 shares during the last quarter. Vanguard Personalized Indexing Management LLC purchased a new stake in shares of Teladoc Health during the second quarter valued at $133,000. Benjamin F. Edwards & Company Inc. lifted its position in Teladoc Health by 209.8% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 5,015 shares of the health services provider’s stock worth $49,000 after acquiring an additional 3,396 shares during the period. Bank of Montreal Can raised its stake in shares of Teladoc Health by 470.6% in the second quarter. Bank of Montreal Can now owns 94,466 shares of the health services provider’s stock worth $926,000 after purchasing an additional 77,909 shares during the last quarter. Finally, Xponance Inc. purchased a new stake in Teladoc Health in the second quarter valued at approximately $105,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.